Glio-vascular changes during ageing in wild-type and Alzheimer׳s disease-like APP/PS1 mice
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Vascular and glial involvement in the development of neurodegenerative disorders, such as Alzheimer’s disease (AD), and age-related brain vulnerabilities has been suggested. Therefore, we sought to: i) investigate which vascular and glial events are evident in ageing and/or AD, ii) to establish the temporal evolution of vascular and glial changes in AD-like and wild-type (WT) mice and iii) to relate them to amyloid-β (Aβ) accumulation. We examined immunohistochemically hippocampi and cortex from APP/PS1dE9 and WT C57BL/6 mice along ageing and disease progression (young-adulthood, middle- and old-age). Ageing resulted in the increase in receptor for advanced glycation endproducts expression, as well as the entrance of thrombin and albumin in hippocampus parenchyma. In contrast, the loss of platelet-derived growth factor receptor-β (PDGFR-β) positive cells, in both regions, was only related to AD pathogenesis. Hypovascularization was affected by both ageing and AD in the hippocampus, but resulted from the interaction between both factors in the cortex. Astrogliosis was a result of AD in hippocampus and by both factors in cortex, while microgliosis was associated with fibrillar amyloid plaques in AD-like mice and with the interaction between both factors in each of the studied regions. In sum, these data show that senile plaques precede vascular and glial alterations just in hippocampus, whereas in cortex, vascular and glial alterations, namely loss of PDGFR-β-positive cells and astrogliosis, accompanied the first senile plaques. Hence, this study points to vascular and glial events that co-exist with AD pathogenesis and age-related brain vulnerabilities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: Pericyte loss influences Alzheimer-like neurodegeneration in mice
Sagare, A. P., Bell, R. D., Zhao, Z., Ma, Q., Winkler, E. A., Ramanathan, A., & Zlokovic, B. V. (2013) · Nature Communications · doi:10.1038/ncomms3932 · Cited by 589 · cited 3×
“Moreover, we found that AD-like transgenic mice have a greater loss of total and perivascular PDGFR-β-positive cells than age-matched controls, which agrees with previous reports (Bell et al., 2010; Sagare et al., 2013; Sengillo et al., 2013).”
BackgroundResultRetractedNeuropathological alterations in Alzheimer disease
Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345 · cited 2×
“Alzheimer’s disease (AD) is an age-related neurodegenerative disease characterized by intracellular neurofibrillary tangles of hyperphosphorylated tau (tauopathy), amyloid-β peptide (Aβ) extracellular aggregates (amyloidopathy), oxidative stress, inflammation and premature neuronal apoptosis (Serrano-Pozo et al., 2011…”
BackgroundNeurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
Pericytes regulate the blood–brain barrier
Armulik, A., Genové, G., Mäe, M., Nisancioglu, M. H., Wallgard, E., Niaudet, C., He, L., Norlin, J., Lindblom, P., Strittmatter, K., et al. (2010) · Nature · doi:10.1038/nature09522 · Cited by 2,843 · cited 2×
“, 2010), as pointed out in our study based on the detection of thrombin and albumin in brain parenchyma, which is in line with previous reports (Armulik et al., 2010; Baloyannis and Baloyannis, 2012; Daneman et al., 2010; Sengillo et al., 2013).”
ResultPericytes are required for blood–brain barrier integrity during embryogenesis
Daneman, R., Zhou, L., Kebede, A. A., & Barres, B. A. (2010) · Nature · doi:10.1038/nature09513 · Cited by 2,128
Blood-brain barrier breakdown in the aging human hippocampus
Montagne, A., Barnes, S. R., Sweeney, M. D., Halliday, M. R., Sagare, A. P., Zhao, Z., Toga, A. W., Jacobs, R. E., Liu, C. Y., Amezcua, L., et al. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.032 · Cited by 2,102
Jankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575 · cited 2×
“APPswe/PS1ΔE9 Tg mice express two human genes of familial AD, the APP K594N/M595L Swedish and Presenilin 1 delta E9 (PS1ΔE9) (deletion of exon 9) under a mouse prion protein promotor (Jankowsky et al., 2004).”
BackgroundBell, R. D., Winkler, E. A., Sagare, A. P., Singh, I., LaRue, B., Deane, R., & Zlokovic, B. V. (2010) · Neuron · doi:10.1016/j.neuron.2010.09.043 · Cited by 1,448 · cited 14×
“We studied, for the first time, the temporal evolution of pericytes from young adulthood to old age during healthy ageing and AD progression using the commonly used pericyte marker PDGFR-β (Bell et al., 2010; Sá-Pereira et al., 2012).”
BackgroundMethodResultInfluentialCerebral microvascular pathology in aging and Alzheimer's disease
Farkas, E., & Luiten, P. G. M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00068-x · Cited by 1,102 · cited 2×
“…in hippocampus and cortex is a hallmark of normal ageing and is even more pronounced in AD patients (Bell and Ball, 1986; Bell and Ball, 1990; Farkas and Luiten, 2001; Fischer et al., 1990), aged healthy mice (Jucker et al., 1990; Sonntag et al., 1997) and AD mouse models (Bailey et al.,…”
BackgroundEndothelial-Mural Cell Signaling in Vascular Development and Angiogenesis
Gaengel, K., Genové, G., Armulik, A., & Betsholtz, C. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.161521 · Cited by 933
Cited by
Senatorov, V. V., Friedman, A. R., Milikovsky, D. Z., Ofer, J., Saar-Ashkenazy, R., Charbash, A., Jahan, N., Chin, G., Mihaly, E., Lin, J. M., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw8283 · Cited by 257
“There have been very few rodent studies that assess BBB status in aging (16), and whether and how BBB breakdown affects brain function in aging remain unclear.”
BackgroundAge-associated changes in the blood-brain barrier: comparative studies in human and mouse.
Goodall, E. F., Wang, C., Simpson, J. E., Baker, D. J., Drew, D. R., Heath, P. R., Saffrey, M. J., Romero, I. A., & Wharton, S. B. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12408 · Cited by 120
Inhibition of formyl peptide receptors improves the outcome in a mouse model of Alzheimer disease
Schröder, N., Schaffrath, A., Welter, J. A., Putzka, T., Griep, A., Ziegler, P., Brandt, E., Samer, S., Heneka, M. T., Kaddatz, H., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01816-2 · Cited by 43
ADAMTS13 maintains cerebrovascular integrity to ameliorate Alzheimer-like pathology
Cao, Y., Xu, H., Zhu, Y., Shi, M.-J., Wei, L., Zhang, J., Cheng, S., Shi, Y., Tong, H., Kang, L., et al. (2019) · PLOS Biology · doi:10.1371/journal.pbio.3000313 · Cited by 31
“At 12 months, APPPS1 mice displayed 31% and 36% reductions in cortical and hippocampal capillary density, respectively, when compared with WT littermates, as reported [28,29].”
ResultRetractedEdler, M. K., Munger, E. L., Maycon, H., Hopkins, W. D., Hof, P. R., Sherwood, C. C., & Raghanti, M. A. (2023) · Journal of Neuroscience Research · doi:10.1002/jnr.25167 · Cited by 23
“…and rodents that demonstrated an increase in GFAP mRNA, protein, and qualitative measures with age (Beach et al., 1989; David et al., 1997; Finch et al., 2002; Goss et al., 1991; Janota et al., 2015; Landfield et al., 1977; Morgan et al., 1997; Nichols et al., 1993; O'Callaghan & Miller, 1991).”
BackgroundDimethyl fumarate does not mitigate cognitive decline and β-amyloidosis in female APPPS1 mice
Möhle, L., Brackhan, M., Bascuñana, P., & Pahnke, J. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147579 · Cited by 21
Metadata
- Authors
- Janota, C. S., Brites, D., Lemere, C. A., & Brito, M. A.
- Venue
- Brain Research
- Publisher
- Elsevier BV
- Published
- 2015-09
- Volume
- 1620
- Pages
- 153-168
- ISSN
- 0006-8993 (ISSN-L)
- OpenAlex
- W654966828
- Cited by
- 57
- References
- 28
- FWCI
- 2.37
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.